Jul 16, 2026 04:01PM
Jul 16, 2026 04:00PM
Apr 7, 2026 07:37AM
Mar 18, 2026 07:02AM
Mar 18, 2026 07:00AM
Mar 4, 2026 07:00AM
Feb 18, 2026 08:00AM Marvel Biosciences Secures Funding to Develop Child-Friendly Liquid Formulation for Neurodevelopmental Disorders
Feb 3, 2026 04:30PM
Aug 18, 2025 05:05PM
Apr 30, 2025 07:00AM
Apr 16, 2025 07:00AM
Apr 14, 2025 07:00AM
Mar 17, 2025 07:00AM
Mar 13, 2025 07:00AM Marvel Announces First of Two Final Data Sets from Rett Syndrome Study: MB-204 Significantly Outperforms Trofinetide
Mar 11, 2025 07:00AM
Jan 16, 2025 07:00AM
Jan 7, 2025 07:00AM
Nov 26, 2024 07:00AM
Nov 21, 2024 07:00AM
Nov 7, 2024 07:00AM
Oct 10, 2024 09:00AM Marvel Biosciences Shares Positive Results of MB204 in the Oprm1 Model of Autism
Aug 13, 2024 09:00AM
Jul 24, 2024 09:00AM
Jul 9, 2024 09:00AM

419,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All